Regeneron SANOFI Study Dupilumab IL-13Ra2 Signaling
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 24, 2022
End Date
December 31, 2025
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 24, 2022
End Date
December 31, 2025